Home > Bioptigen Salary

Bioptigen Salary

  • 10
  • 86
  • 50
Bioptigen average salary is $63,334, median salary is $62,000 with a salary range from $62,000 to $66,000.
Bioptigen salaries are collected from government agencies and companies. Each salary is associated with a real job position. Bioptigen salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
62,000
Average
63,334
Median
62,000
High
66,000
Total 2 Bioptigen Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Software Quality Assurance 62,000-62,000 Orlando, FL, 32801 2012 Bioptigen Software Quality Assurance Salaries (3)
Bioptigen Orlando, FL Salaries
Software Quality Assurance 62,000-66,000 Jersey City, NJ, 07097 2012 Bioptigen Software Quality Assurance Salaries (3)
Bioptigen Jersey City, NJ Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Bioptigen salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Bioptigen Jobs
See more Bioptigen Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
221

All Patents

91

Grant Patents

124

Patents Pending

70

Patents Families

More Recent
Bioptigen... Information
  • Bioptigen Inc
  • Industry: Healthcare Facilities
  • City: Research Triangle Park, NC
  • Bioptigen Inc. has pioneered a new class of in vivo optical imaging systems for biomedical applications. These systems enable real-time non-invasive imaging of internal tissue microstructure, advancing critical applications in drug development, genetics research, tissue engineering and medical vision.Bioptigen, a spin-out from the Biomedical Engineering Department in the Pratt School of Engineering at Duke University, was incorporated in North Carolina in August, 2004 to commercialize technologies originating in the laboratories of Professor Joseph Izatt.